WEST COLUMBIA, S.C. — U.S. drug regulators issued a report this week detailing issues at Nephron Pharmaceuticals. The inspection was conducted in February at the facility in West Columbia, which ...
Add Yahoo as a preferred source to see more of our stories on Google. A recent inspection at a South Carolina drug production facility flagged several problems with how the company was producing drugs ...
In an exhaustive warning letter earlier this month to Nephron Pharmaceuticals, it took the FDA 4,273 words to break down the problems at the generic drug manufacturer’s plant in South Carolina and ...
Lou Kennedy, CEO of Nephron Pharmaceuticals takes Sen. Lindsey Graham on a 2020 tour of the facility in Cayce. 5/15/20 Tracy Glantz tglantz@thestate.com Nephron Pharmaceuticals has furloughed at least ...
A recent inspection at a South Carolina drug production facility flagged several problems with how the company was producing drugs for the mass market, little more than a year after the same facility ...